buspirone has been researched along with Lung Diseases, Obstructive in 2 studies
Buspirone: An anxiolytic agent and serotonin receptor agonist belonging to the azaspirodecanedione class of compounds. Its structure is unrelated to those of the BENZODIAZAPINES, but it has an efficacy comparable to DIAZEPAM.
buspirone : An azaspiro compound that is 8-azaspiro[4.5]decane-7,9-dione substituted at the nitrogen atom by a 4-(piperazin-1-yl)butyl group which in turn is substituted by a pyrimidin-2-yl group at the N(4) position.
Lung Diseases, Obstructive: Any disorder marked by obstruction of conducting airways of the lung. AIRWAY OBSTRUCTION may be acute, chronic, intermittent, or persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to determine if buspirone would alleviate anxiety and improve exercise tolerance of anxious patients with chronic airflow obstruction (CAO)." | 9.07 | Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. ( Avalos, K; Despars, JA; Light, RW; Singh, NP; Stansbury, DW, 1993) |
| "Buspirone is an anxiolytic agent that appears to have no sedative effects." | 6.67 | Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. ( Argyropoulou, P; Georgopoulos, D; Koukou, A; Patakas, D; Vasiliadis, P, 1993) |
| "The objective of this study was to determine if buspirone would alleviate anxiety and improve exercise tolerance of anxious patients with chronic airflow obstruction (CAO)." | 5.07 | Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety. ( Avalos, K; Despars, JA; Light, RW; Singh, NP; Stansbury, DW, 1993) |
| "Buspirone is an anxiolytic agent that appears to have no sedative effects." | 2.67 | Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease. ( Argyropoulou, P; Georgopoulos, D; Koukou, A; Patakas, D; Vasiliadis, P, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Argyropoulou, P | 1 |
| Patakas, D | 1 |
| Koukou, A | 1 |
| Vasiliadis, P | 1 |
| Georgopoulos, D | 1 |
| Singh, NP | 1 |
| Despars, JA | 1 |
| Stansbury, DW | 1 |
| Avalos, K | 1 |
| Light, RW | 1 |
2 trials available for buspirone and Lung Diseases, Obstructive
| Article | Year |
|---|---|
Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease.
Topics: Adult; Aged; Buspirone; Double-Blind Method; Dyspnea; Exercise Tolerance; Forced Expiratory Volume; | 1993 |
Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety.
Topics: Aged; Anxiety; Buspirone; Dose-Response Relationship, Drug; Exercise Test; Exercise Tolerance; Human | 1993 |